Design Therapeutics, Inc.DSGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.7%
5Y CAGR+57.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+6.7%/yr
Annual compound
5Y CAGR
+57.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $59.13M | +33.3% |
| 2024 | $44.35M | -22.3% |
| 2023 | $57.06M | +17.4% |
| 2022 | $48.61M | +96.2% |
| 2021 | $24.78M | +308.9% |
| 2020 | $6.06M | +266.4% |
| 2019 | $1.65M | - |